Brighton Jones LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-28,901
| Closed | -$8.16M | – | 96 |
|
|
2025
Q3 | $8.16M | Buy |
28,901
+116
| +0.4% | +$33.6K | 0.2% | 64 |
|
|
2025
Q2 | $8.04M | Sell |
28,785
-215
| -0.7% | -$60.9K | 0.22% | 61 |
|
|
2025
Q1 | $9.03M | Buy |
29,000
+1,532
| +6% | +$452K | 0.29% | 49 |
|
|
2024
Q4 | $7.16M | Buy |
27,468
+5,226
| +23% | +$1.55M | 0.21% | 63 |
|
|
2024
Q3 | $7.17M | Sell |
22,242
-1,536
| -6% | -$502K | 0.27% | 52 |
|
|
2024
Q2 | $7.43M | Sell |
23,778
-250
| -1% | -$73.4K | 0.25% | 54 |
|
|
2024
Q1 | $6.83M | Buy |
24,028
+552
| +2% | +$162K | 0.25% | 55 |
|
|
2023
Q4 | $6.76M | Buy |
23,476
+786
| +3% | +$214K | 0.29% | 54 |
|
|
2023
Q3 | $6.1M | Buy |
22,690
+952
| +4% | +$238K | 0.31% | 49 |
|
|
2023
Q2 | $4.83M | Buy |
21,738
+523
| +2% | +$121K | 0.24% | 62 |
|
|
2023
Q1 | $5.13M | Buy |
21,215
+304
| +1% | +$74.6K | 0.29% | 52 |
|
|
2022
Q4 | $5.49M | Sell |
20,911
-317
| -1% | -$85K | 0.33% | 39 |
|
|
2022
Q3 | $4.79M | Buy |
21,228
+300
| +1% | +$72.7K | 0.28% | 42 |
|
|
2022
Q2 | $5.09M | Sell |
20,928
-337
| -2% | -$82.6K | 0.29% | 38 |
|
|
2022
Q1 | $5.14M | Sell |
21,265
-514
| -2% | -$118K | 0.24% | 42 |
|
|
2021
Q4 | $4.9M | Buy |
21,779
+107
| +0.5% | +$22.6K | 0.23% | 49 |
|
|
2021
Q3 | $4.61M | Buy |
21,672
+1
| +0% | +$230 | 0.24% | 47 |
|
|
2021
Q2 | $5.28M | Buy |
21,671
+147
| +0.7% | +$36.2K | 0.27% | 38 |
|
|
2021
Q1 | $5.36M | Buy |
21,524
+100
| +0.5% | +$23.9K | 0.32% | 31 |
|
|
2020
Q4 | $4.93M | Buy |
21,424
+10,640
| +99% | +$2.45M | 0.3% | 36 |
|
|
2020
Q3 | $2.74M | Buy |
10,784
+1,352
| +14% | +$335K | 0.19% | 48 |
|
|
2020
Q2 | $2.23M | Sell |
9,432
-7
| -0.1% | -$1.6K | 0.18% | 53 |
|
|
2020
Q1 | $1.91M | Buy |
9,439
+142
| +2% | +$31K | 0.2% | 47 |
|
|
2019
Q4 | $2.24M | Buy |
9,297
+294
| +3% | +$64.8K | 0.24% | 54 |
|
|
2019
Q3 | $1.74M | Sell |
9,003
-851
| -9% | -$163K | 0.2% | 65 |
|
|
2019
Q2 | $1.82M | Sell |
9,854
-93
| -0.9% | -$16.7K | 0.21% | 62 |
|
|
2019
Q1 | $1.89M | Buy |
9,947
+51
| +0.5% | +$9.74K | 0.23% | 61 |
|
|
2018
Q4 | $1.93M | Buy |
9,896
+802
| +9% | +$156K | 0.28% | 47 |
|
|
2018
Q3 | $1.89M | Buy |
9,094
+6,472
| +247% | +$1.28M | 0.23% | 51 |
|
|
2018
Q2 | $484K | Buy |
2,622
+108
| +4% | +$19.1K | 0.06% | 173 |
|
|
2018
Q1 | $429K | Sell |
2,514
-377
| -13% | -$69.2K | 0.06% | 174 |
|
|
2017
Q4 | $503K | Buy |
2,891
+192
| +7% | +$34K | 0.06% | 152 |
|
|
2017
Q3 | $503K | Buy |
2,699
+58
| +2% | +$10.3K | 0.06% | 151 |
|
|
2017
Q2 | $455K | Sell |
2,641
-1
| -0% | -$163 | 0.06% | 145 |
|
|
2017
Q1 | $433K | Buy |
2,642
+1,200
| +83% | +$199K | 0.1% | 63 |
|
|
2016
Q4 | $211K | Sell |
1,442
-1,098
| -43% | -$165K | 0.08% | 93 |
|
|
2016
Q3 | $424K | Sell |
2,540
-157
| -6% | -$26.5K | 0.07% | 143 |
|
|
2016
Q2 | $410K | Buy |
2,697
+38
| +1% | +$5.91K | 0.07% | 131 |
|
|
2016
Q1 | $399K | Sell |
2,659
-147
| -5% | -$21.8K | 0.07% | 131 |
|
|
2015
Q4 | $456K | Buy |
2,806
+3
| +0.1% | +$472 | 0.09% | 113 |
|
|
2015
Q3 | $388K | Buy |
2,803
+489
| +21% | +$77.1K | 0.08% | 121 |
|
|
2015
Q2 | $355K | Buy |
2,314
+1
| +0% | +$160 | 0.08% | 122 |
|
|
2015
Q1 | $370K | Sell |
2,313
-3,089
| -57% | -$486K | 0.08% | 120 |
|
|
2014
Q4 | $861K | Sell |
5,402
-1,153
| -18% | -$180K | 0.2% | 58 |
|
|
2014
Q3 | $921K | Sell |
6,555
-148
| -2% | -$19.3K | 0.21% | 59 |
|
|
2014
Q2 | $793K | Buy |
6,703
+4,027
| +150% | +$466K | 0.18% | 61 |
|
|
2014
Q1 | $330K | Sell |
2,676
-159
| -6% | -$19.3K | 0.08% | 126 |
|
|
2013
Q4 | $323K | Buy |
+2,835
| New | +$322K | 0.07% | 127 |
|
Other funds holding AMGN
Brighton Jones LLC's AMGN Position: Q4 2025 in Review
Brighton Jones LLC sold out of Amgen (AMGN) in Q4 2025, closing a stake of 28,901 shares — an estimated $8.16M sold.
Brighton Jones LLC first reported a position in AMGN in Q4 2013 and held it in 48 quarters. The position peaked at $9.03M in Q1 2025. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Brighton Jones LLC reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Brighton Jones LLC sold 28,901 Amgen shares in Q4 2025, an estimated $8.16M.
- Brighton Jones LLC first reported a position in Amgen in Q4 2013 and held it in 48 quarters.
- Brighton Jones LLC's Amgen position peaked at $9.03M in Q1 2025.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Brighton Jones LLC's 13F filing for Q4 2025, filed 27 Jan 2026.